LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: Clinical and research implications in iron disorders

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 10, 2015, Pages 1557-1567

  Lefebvre, Thibaud ^a,b,c,d   Dessendier, Nathalie ^d   Houamel, Dounia ^a,c   Ialy Radio, Nathalie ^b   Kannengiesser, Caroline ^a,e   Manceau, Hana ^a,c,d   Beaumont, Carole ^a,c   Nicolas, Gael ^a,c   Gouya, Laurent ^a,b,c,d   Puy, Hervé ^a,b,c,d   Karim, Zoubida ^a,c  

^a CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c GREX   (France)

^d HÔPITAL LOUIS MOURIER   (France)

^e BICHAT HOSPITAL   (France)

Author keywords

ELISA; hepcidin; human; iron deficiency; mass spectrometry; mouse

Indexed keywords

C REACTIVE PROTEIN; HEPCIDIN; HEPCIDIN 25; UNCLASSIFIED DRUG; HAMP1 PROTEIN, MOUSE; HEPCIDIN 25, HUMAN; IRON;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANION EXCHANGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE; GENE EXPRESSION; GENE MUTATION; HAMP1 GENE; HEMOCHROMATOSIS; HEMOLYTIC ANEMIA; HEPCIDIN LEVEL; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; KIDNEY FUNCTION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; MICROCYTIC ANEMIA; MOLECULAR DIAGNOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; YOUNG ADULT; AMINO ACID SEQUENCE; ANIMAL; BLOOD; MIDDLE AGED; MOLECULAR GENETICS; PROCEDURES;

ADULT; AMINO ACID SEQUENCE; ANEMIA, IRON-DEFICIENCY; ANIMALS; CHROMATOGRAPHY, LIQUID; FEMALE; HEPCIDINS; HUMANS; IRON; MALE; MICE; MIDDLE AGED; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84941243894     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-1093     Document Type: Article

References (38)

1. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001;98:8780-5.
2. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011;117:4425-33.
3. Steinbicker AU, Muckenthaler MU. Out of balance - systemic iron homeostasis in iron-related disorders. Nutrients 2013;5:3034-61.
4. Peyssonnaux C, Zinkernagel AS, Datta V, Lauth X, Johnson RS, Nizet V. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 2006;107:3727-32.
5. Schwarz P, Kubler JA, Strnad P, Muller K, Barth TF, Gerloff A, et al. Hepcidin is localised in gastric parietal cells, regulates acid secretion and is induced by Helicobacter pylori infection. Gut 2012;61:193-201.
6. Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006;131:788-96.
7. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3.
8. Delaby C, Pilard N, Goncalves AS, Beaumont C, Canonne-Hergaux F. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood 2005;106:3979-84.
9. Ganz T, Nemeth E. Iron sequestration and anemia of inflammation. Semin Hematol 2009;46:387-93.
10. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 2014;46:678-84.
11. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011;57:1650-69.
12. Rochat B, Peduzzi D, McMullen J, Favre A, Kottelat E, Favrat B, et al. Validation of hepcidin quantification in plasma using LC-HRMS and discovery of a new hepcidin isoform. Bioanalysis 2013;5:2509-20.
13. Jordan JB, Poppe L, Haniu M, Arvedson T, Syed R, Li V, et al. Hepcidin revisited, disulfide connectivity, dynamics, and structure. J Biol Chem 2009;284:24155-67.
14. Konz T, Montes-Bayon M, Vaulont S. Hepcidin quantification: methods and utility in diagnosis. Metallomics 2014;6:1583-90.
15. Lou DQ, Nicolas G, Lesbordes JC, Viatte L, Grimber G, Szajnert MF, et al. Functional differences between hepcidin 1 and 2 in transgenic mice. Blood 2004;103:2816-21.
16. Lesbordes-Brion JC, Viatte L, Bennoun M, Lou DQ, Ramey G, Houbron C, et al. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 2006;108:1402-5.
17. Tjalsma H, Laarakkers CM, van Swelm RP, Theurl M, Theurl I, Kemna EH, et al. Mass spectrometry analysis of hepcidin peptides in experimental mouse models. PLoS One 2011;6:e16762.
18. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood 2008;112:4292-7.
19. Guillem F, Kannengiesser C, Oudin C, Lenoir A, Matak P, Donadieu J, et al. Inactive matriptase-2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity. Hum Mutat 2012;33:1388-96.
20. Lasocki S, Millot S, Andrieu V, Letteron P, Pilard N, Muzeau F, et al. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia. Crit Care Med 2008;36:2388-94.
21. Moulouel B, Houamel D, Delaby C, Tchernitchko D, Vaulont S, Letteron P, et al. Hepcidin regulates intrarenal iron handling at the distal nephron. Kidney Int 2013;84:756-66.
22. Li H, Rose MJ, Tran L, Zhang J, Miranda LP, James CA, et al. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. J Pharmacol Toxicol Methods 2009;59:171-80.
23. Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009;94:1748-52.
24. Murphy AT, Witcher DR, Luan P, Wroblewski VJ. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 2007;110:1048-54.
25. Itkonen O, Parkkinen J, Stenman UH, Hamalainen E. Preanalytical factors and reference intervals for serum hepcidin LC-MS/MS method. Clin Chim Acta 2012;413:696-701.
26. Wolff F, Deleers M, Melot C, Gulbis B, Cotton F. Hepcidin-25: measurement by LC-MS/MS in serum and urine, reference ranges and urinary fractional excretion. Clin Chim Acta 2013;423:99-104.
27. Kroot JJ, van Herwaarden AE, Tjalsma H, Jansen RT, Hendriks JC, Swinkels DW. Second round robin for plasma hepcidin methods: first steps toward harmonization. Am J Hematol 2012;87: 977-83.
28. Anderson DS, Heeney MM, Roth U, Menzel C, Fleming MD, Steen H. High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urine. Anal Chem 2011;82:1551-5.
29. Hwang S-I, Lee Y-Y, Park J-O, Norton HJ, Clemens E, Schrum LW, et al. Effects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC-MS/MS method. Clin Chim Acta 2011;412:2241-7.
30. Kobold U, Dulffer T, Dangl M, Escherich A, Kubbies M, Roddiger R, et al. Quantification of hepcidin-25 in human serum by isotope dilution micro-HPLC-tandem mass spectrometry. Clin Chem 2008;54:1584-6.
31. Houbart V, Cobraiville G, Lecomte F, Debrus B, Hubert P, Fillet M. Development of a nano-liquid chromatography on chip tandem mass spectrometry method for high-sensitivity hepcidin quantitation. J Chromatogr A 2011;1218:9046-54.
32. Delaby C, Vialaret J, Bros P, Gabelle A, Lefebvre T, Puy H, et al. Clinical measurement of Hepcidin-25 in human serum: is quantitative mass spectrometry up to the job? EuPA Open Proteomics 2014;3:60-7.
33. Murao N, Ishigai M, Yasuno H, Shimonaka Y, Aso Y. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom 2007;21:4033-8.
34. Brasse-Lagnel C, Karim Z, Letteron P, Bekri S, Bado A, Beaumont C. Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. Gastroenterology 2011;140:1261-71 e1.
35. Lasocki S, Baron G, Driss F, Westerman M, Puy H, Boutron I, et al. Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Med 2010;36:1044-8.
36. Delaby C, Beaumont C. [Serum hepcidin assay in 2011: where do we stand?]. Ann Biol Clin (Paris) 2012;70:377-86.
37. De Falco L, Sanchez M, Silvestri L, Kannengiesser C, Muckenthaler MU, Iolascon A, et al. Iron refractory iron deficiency anemia. Haematologica 2013;98:845-53.
38. Guillem F, Lawson S, Kannengiesser C, Westerman M, Beaumont C, Grandchamp B. Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood 2008;112:2089-91.